Skip to content
Croma logo — From submission to prescription we break the market access b...

Croma

From submission to prescription we break the market access barriers

Founded 2005 Greece Greece 15 employees Pharmaceutical, Marketing

General Information

Company Name Croma
Founded Year 2005
Location Greece Greece
Employees 15
Industries Pharmaceutical, Marketing
Social

BounceWatch is an independent company data service, not affiliated with Croma. To contact Croma, visit croma.gr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Croma compare?

A PDF of Croma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Croma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Croma

Croma is a Greek startup founded in 2005 with the mission to facilitate market access for pharmaceutical products. Founded by Venia Allamani and Athina Moissidou, who have extensive experience in Regulatory Affairs and Market Access from their leadership roles in multinational pharmaceutical companies, including AstraZeneca, Bayer, and Sandoz. Croma aims to provide strategic support to drive products effectively into the Greek market, emphasizing the significance of Regulatory Affairs in the ever-evolving health sector. Understanding the criticality of Market Access, Croma offers personalized services to assist in navigating the complex approval procedures for product launches in Greece. Despite limited investment information, Croma's focus on the pharmaceutical and marketing industries, along with its Greek headquarters, positions it as a promising player in the healthcare market. With its dedication to overcoming market access barriers, Croma presents an intriguing opportunity for potential investors seeking exposure to the pharmaceutical sector in Greece.

Business keywords: pharmaceutical market access, regulatory affairs, Greek market entry, pharmaceutical industry, healthcare market, market approval procedures, market access strategy, pharmaceutical business, healthcare regulations, health environment, drug approval process, pharmaceutical consulting, healthcare market dynamics

No funding data available for Croma yet.

Croma Alternatives & Competitors

View All Alternatives
Croma vs

We are your partner for the registration, distribution & promotion of your pharmaceutical products i...

31 employees
Logistics, Pharmaceutical
Croma vs

Arex Advisor offers regulatory affairs expertise to the pharmaceutical and biotech industry.

39 employees
Pharmaceutical, Marketing
Croma vs
Zealth
Zealth Denmark

Zealth helps healthcare companies bring their products to patients by putting our customers first.

14 employees
Health Care, Pharmaceutical

FAQ About Croma

From submission to prescription we break the market access barriers
Croma was founded in 2005.
Croma is headquartered in Greece.
Croma operates in Pharmaceutical and Marketing. Its work centres on pharmaceutical market access, regulatory affairs, Greek market entry and pharmaceutical industry.
Croma has approximately 15 employees.
Top alternatives and competitors to Croma include Energia Pharma Services, Arex Advisor, Zealth, Magnolia Market Access, PROMO-PHARMA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Croma and Energia Pharma Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Croma, https://bouncewatch.com/company/croma, updated 13 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout